Apple is increasing transparency around health-focused apps available on its App Store, a move impacting developers and users in the European Economic Area (EEA), the United Kingdom, and the United States. The company will now require developers to clearly indicate whether their app is a regulated medical device, and will display this status directly on the app’s product page. This change, announced this week, aims to provide users with clearer information about the level of regulatory scrutiny an app has undergone, particularly those dealing with sensitive health data and functions. The core issue is regulated medical device apps, which are defined as those used for diagnosis, prevention, monitoring, or treatment of diseases and physiological conditions.
The update comes as the use of mobile health apps continues to grow rapidly. According to a 2023 report by Statista, the mobile health market is projected to reach $332.80 billion in 2024. With this growth comes increased scrutiny from regulatory bodies like the U.S. Food and Drug Administration (FDA) and its counterparts in Europe and the UK. Apps that fall under the definition of a medical device are subject to stricter requirements regarding safety, efficacy, and data privacy. This new App Store policy is designed to help users understand which apps are held to those standards.
What Defines a Regulated Medical Device App?
Determining whether an app qualifies as a regulated medical device isn’t always straightforward. Apple has outlined two primary criteria that trigger the requirement to declare a status in App Store Connect. First, if an app’s primary or secondary category is “Health & Fitness” or “Medical,” developers must provide information. Second, if the app is flagged during the age-rating questionnaire as containing frequent references to “Medical” or “Treatment Information,” it also falls under the new requirements. This questionnaire is part of the app submission process and helps Apple categorize apps appropriately.
The FDA, for example, regulates medical devices based on risk. Class I devices pose the lowest risk and are subject to the least regulatory control, while Class III devices are the highest risk and require the most rigorous premarket approval. The FDA’s website provides detailed information on device classification and the regulatory pathways involved. Similar regulatory frameworks exist in the EEA, governed by the Medical Device Regulation (MDR) 2017/746, and in the UK, following guidance from the Medicines and Healthcare products Regulatory Agency (MHRA).
Timeline and Requirements for Developers
The new policy is effective immediately for all new apps meeting the criteria. Developers submitting new apps in the Health & Fitness or Medical categories, or those flagged for medical content, must now declare their regulated medical device status in App Store Connect. For existing apps already distributed in these regions, the deadline to declare status is early 2027. However, Apple has warned that developers who fail to declare their app’s status by this deadline will be unable to submit updates. This effectively means apps could grow stagnant if developers don’t comply.
The declaration process requires developers to provide not only a “Yes” or “No” answer but also relevant regulatory information, including contact details and safety information. Apple’s developer documentation provides a detailed guide on how to provide this information. Developers who are unsure whether their app qualifies as a regulated medical device are encouraged to consult with legal counsel specializing in healthcare regulations.
Impact on App Developers and Users
This change is expected to have a significant impact on both app developers and users. Developers will need to carefully assess their apps to determine if they meet the criteria for a regulated medical device and ensure they comply with the new requirements. This may involve additional paperwork, regulatory filings, and ongoing compliance efforts. For users, the increased transparency will allow them to make more informed decisions about the health apps they use, understanding the level of validation and oversight the app has undergone.
Some developers have expressed concerns about the potential for increased regulatory burden and the cost of compliance. However, many also acknowledge the importance of transparency and user safety. “It’s a great step towards building trust in the digital health space,” said Dr. Emily Carter, a digital health consultant. “Users need to know what level of scrutiny an app has been subjected to before relying on it for their health.”
Looking Ahead
Apple’s move is part of a broader trend towards increased regulation of digital health technologies. Regulatory bodies around the world are grappling with how to effectively oversee the rapidly evolving landscape of mobile health apps and wearable devices. The European Commission is currently reviewing the MDR to address implementation challenges and ensure a consistent approach across member states. In the US, the FDA continues to refine its guidance on regulating software as a medical device (SaMD). The next major checkpoint for developers will be ensuring compliance with these evolving regulations as they are updated and clarified.
This increased scrutiny is likely to continue as digital health technologies become more integrated into mainstream healthcare. Users should always consult with a qualified healthcare professional before making any decisions about their health based on information obtained from a mobile app. For more information on regulated medical devices, visit the FDA’s website or the European Commission’s medical devices sector page.
Have thoughts on Apple’s new policy? Share your comments below, and let us know how you think this will impact the future of digital health.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or legal advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
